Navigation Links
Cardium Announces Reverse Stock Split
Date:7/18/2013

SAN DIEGO, July 18, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) announced a 1-for-20 reverse split of the Company's issued and outstanding common stock effective at the open of the NYSE MKT Exchange today, July 18, 2013.  Accordingly, each 20 shares of common stock and equivalents will be converted into one share of common stock.  In addition, proportional adjustments will be made to Cardium's outstanding warrants and stock options.  As a result of the split, the number of shares of common stock to be received upon conversion of any of Cardium's convertible preferred stock, including the preferred stock acquired in April 2013 and any additional shares, will be reduced by 20-fold. In addition, the conversion price of convertible preferred stock, which is subject to adjustment as previously described, will be increased by 20-fold.

(Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

At this morning's market open, Cardium's common stock will trade under new CUSIP number 141916304.  The Company's trading symbol, CXM, will remain unchanged.  As a result of the reverse stock split, the number of issued and outstanding common shares will be reduced to approximately 6.5 million.  The number of authorized shares and the par value per share of common stock will remain unchanged.  No fractional shares of common stock will be issued as a result of the reverse stock split and shareholders of record will receive cash in lieu of fractional shares to which they would otherwise be entitled, based upon the price of Cardium's common stock at close of market on July 17, 2013.

Cardium stockholders who hold their shares in certificated form will receive a communication from Computershare Trust Company regarding the exchange of outstanding stock certificates into new certificates or book entry form. 
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cardium Announces Initial Voting Results And Temporary Adjournment of Annual Meeting To Be Reconvened On June 21, 2013
2. Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
3. Cardium Announces Generx Publication In Molecular Therapy
4. Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
5. Cardium Presents Year-End 2012 Financial Results And Recent Developments
6. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
7. Cardium Receives ISO Certification for Excellagen
8. Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum
9. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
10. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
11. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 /PRNewswire-iReach/ -- VAPETEK™, ... a vegetable-glycol solution for use in portable vaporizers, ... the active ingredients in cannabis, cannabidiol offers consumers ... vaporizer devices, and other vaporizer technology. ... Cannabis naturally contains 483 different compounds which are ...
(Date:7/11/2014)... CHAPEL HILL, N.C. , July 11, 2014 ... component of pharmaceutical marketing and, consequently, organizations are ... specifically for patients. As part of ... learned it,s important to educate, communicate and engage ... from disease awareness to patient empowerment. By mapping ...
(Date:7/11/2014)... 11, 2014 The consumer marketing playbook ... industry sectors to better identify winning tools and ... engage with and understand consumers, as new technologies ... critical purchasing decisions. According to ... one area where organizations can observe a deep ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2New Technologies Transforming Consumer Marketing Research Playbook 2
... CENTER VALLEY, Pa., Oct. 25, 2011 Olympus America ... and a new 5mm HD deflectable videolaparoscope, the ENDOEYE ... 97th Annual Clinical Congress in San Francisco. The VISERA ... advanced image processing to provide the best possible image ...
... Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH ... serious diseases associated with inflammation, today announced it ... study.  PEARL-SC (A randomized, double-blind Phase 2b study ... blisibimod administration in subjects with systemic lupus erythematosus) ...
Cached Medicine Technology:Olympus Introduces World's First Autoclavable 5mm HD Deflectable Videolaparoscope 2Olympus Introduces World's First Autoclavable 5mm HD Deflectable Videolaparoscope 3Anthera Announces Last Patient Enrolled in PEARL-SC Study 2Anthera Announces Last Patient Enrolled in PEARL-SC Study 3Anthera Announces Last Patient Enrolled in PEARL-SC Study 4
(Date:7/13/2014)... Houston, TX (PRWEB) July 13, 2014 The ... for children ranging in age from four months to 12 ... skills and karate classes to birthday parties and Summer Camps, ... the Little Gym of Pearland after spending over ... variety of roles, including Gym Director. , Berry has ...
(Date:7/13/2014)... 2014 Athletes with a certain genetic ... concussions, according to research presented today at the American ... Meeting. The research marks the first of its kind ... known physical events that occur after a head injury. ... allele in the (GT)n genotype were four times more ...
(Date:7/13/2014)... The federal court overseeing thousands of ... against Johnson & Johnson’s Ethicon, Inc. is preparing to ... to get underway next month. According to an Amended ... Southern District of West Virginia on July 9, 2014, ... 2014 at 3:00 p.m. July selection is slated to ...
(Date:7/13/2014)... Recently, 2014QuinceaneraDresses.com, the distinguished special ... new range of gorgeous Quinceanera dresses . ... for elegant Quinceanera outfits is huge. Therefore, 2014QuinceaneraDresses.com ... the company’s newly released dresses are made according ... elegant and vivid. , It is worthy ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Max ... Famer, Chris Mullin, will be the featured guest at ... 26th in Puerto Rico. Attendees will learn about ... participate in two exhibition basketball games and perform in ... supplier of health- and energy-boosting supplements , has ...
Breaking Medicine News(10 mins):Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4
... 7 , 2010 in the World Journal of ... clinical trial, the authors examined if acupuncture could prevent ... with colon cancer in Shanghai, China. Acupuncture did not ... who developed PPOI also suggested acupuncture was not useful ...
... People with Parkinson,s Disease are more likely to display ... circumstances if they are pathological gamblers, according to research ... of Neurology . A number of studies have ... is a frequent impulse control disorder associated mainly with ...
... incidence of colon cancer worldwide. The new study analyses ... between 1951 and 2006 in terms of certain changes ... vegetables...) and also behaviour (physical exercise, sedentary lifestyles). ... Cancer Prevention , show that mortality due to colon ...
... provide the perfect balance between stability and movement in ... partnership begins in the embryo, when the bones are ... issue of Developmental Cell , describes a previously ... development of a strong skeletal system. ,Our ...
... A simple and inexpensive eye test could aid detection and ... earlier stage than is currently possible, according to new research ... Cordeiro & Stephen Moss and published today in Cell ... retinal, and therefore brain cell death, to be directly measured ...
... linked to cholesterol-lowering effect, study suggests , THURSDAY, Jan. ... of the effect of statin drug therapy on the ... used drugs. , Much of the benefit from statins ... the drugs, lowering of blood levels of "bad" LDL ...
Cached Medicine News:Health News:Does electro-acupuncture prevent prolonged postoperative ileus? 2Health News:Parkinson's patients who are pathological gamblers also display abnormal social behavior 2Health News:The first map of colon cancer in Spain is published 2Health News:Weizmann Institute scientists reveal how tendons shape developing bones 2Health News:Seeing a diagnosis: How an eye test could aid Alzheimer's detection 2Health News:More Evidence That Statins Cut Stroke Risk 2Health News:More Evidence That Statins Cut Stroke Risk 3
... The Self-Cath family ... offers patients a variety ... self-catheterization. Each catheter ... medical grade PVC and ...
... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
Used for intermittent catheterization of a male or female patient to provide drainage of urine from the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: